Access cutting-edge liver cancer treatment through this clinical trial at a research site in Miami. Study-provided care at no cost to qualified participants.
Access liver cancer specialists in Miami at no cost
This study follows strict safety protocols and ethical guidelines
All study-related liver cancer treatment provided free
This study will be conducted in 2 parts. The first part is a phase 1 single-agent dose escalation, and dose optimization, study of tegavivint in patients with advanced HCC after failure of at least one line of prior systemic therapy. The second part of the study will begin with a brief dose escalation part for each combination (tegavivint plus cabozantinib or tegavivint plus lenvatinib) followed by a combination dose expansion.
Sponsor: Iterion Therapeutics
Check if you qualify for this liver cancer clinical trial in Miami, FL
If you're searching for liver cancer treatment options in Miami, FL, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Miami research site is actively enrolling participants for this clinical trial. You'll receive care from experienced liver cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.